A detailed history of Black Rock Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Black Rock Inc. holds 11,190,119 shares of ADPT stock, worth $40.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,190,119
Previous 11,421,554 2.03%
Holding current value
$40.5 Million
Previous $56 Million 35.82%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$2.88 - $4.8 $666,532 - $1.11 Million
-231,435 Reduced 2.03%
11,190,119 $35.9 Million
Q4 2023

Feb 13, 2024

SELL
$3.46 - $5.33 $565,896 - $871,742
-163,554 Reduced 1.41%
11,421,554 $56 Million
Q3 2023

Nov 13, 2023

BUY
$5.07 - $8.44 $519,781 - $865,277
102,521 Added 0.89%
11,585,108 $63.1 Million
Q2 2023

Aug 11, 2023

SELL
$6.19 - $8.78 $1.77 Million - $2.51 Million
-285,854 Reduced 2.43%
11,482,587 $77 Million
Q1 2023

May 12, 2023

SELL
$7.8 - $10.11 $4.72 Million - $6.12 Million
-605,756 Reduced 4.9%
11,768,441 $104 Million
Q4 2022

Feb 13, 2023

BUY
$6.26 - $9.34 $14.1 Million - $21.1 Million
2,254,788 Added 22.28%
12,374,197 $94.5 Million
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $7.14 Million - $13.9 Million
1,098,301 Added 12.17%
10,119,409 $72.1 Million
Q2 2022

Aug 12, 2022

BUY
$6.4 - $14.73 $19.5 Million - $45 Million
3,054,607 Added 51.2%
9,021,108 $73 Million
Q1 2022

May 12, 2022

BUY
$10.12 - $28.9 $5.02 Million - $14.3 Million
496,512 Added 9.08%
5,966,501 $82.8 Million
Q4 2021

Feb 10, 2022

SELL
$25.17 - $36.85 $3.03 Million - $4.43 Million
-120,237 Reduced 2.15%
5,469,989 $153 Million
Q3 2021

Nov 09, 2021

BUY
$30.02 - $39.87 $8.12 Million - $10.8 Million
270,369 Added 5.08%
5,590,226 $190 Million
Q2 2021

Aug 11, 2021

BUY
$32.22 - $44.59 $171 Million - $237 Million
5,319,857 New
5,319,857 $217 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $517M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.